Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
March 20, 2019 Off

Pharma Logistics Announces Partnership with PDM Healthcare

By BusinessWire

PDM Healthcare GPO members to have access to traditional and Rapid Credit Program Box and Ship services CHICAGO–(BUSINESS WIRE)–Pharma Logistics…

March 20, 2019 Off

Latin America Pharmaceutical Excipients Market Outlook to 2024 by Functionality and Country – Includes Profiles on Ashland, BASF, DowDuPont, Roquette, and Kerry Group – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Latin America Pharmaceutical Excipients Market by Functionality (Fillers, Coating, Disintegrants, Binders, Lubricants, Preservatives, Emulsifying Agents, Lubricants, Glidants, Diluents),…

Sage Therapeutics gets approval for Zulresso, first new drug to treat postpartum depression
March 20, 2019 Off

Sage Therapeutics gets approval for Zulresso, first new drug to treat postpartum depression

By Dino Mustafić

Sage Therapeutics got clearance from the FDA has approved Zulresso (brexanolone) injection for the treatment of postpartum depression (PPD), and is the first and only medicine specifically approved to treat PPD, the most common medical complication of childbirth.

March 20, 2019 Off

Promega Joins Fight against Colorectal Cancer with $50,000 Donation

By BusinessWire

March 22 is National Lynch Syndrome Awareness Day and March is Colorectal Cancer Awareness Month MADISON, Wis.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CRC?src=hash" target="_blank"gt;#CRClt;/agt;–Ahead…

Cydan Expands Team to Accelerate Development of Innovative Treatments for Patients Living with Rare Diseases
March 20, 2019 Off

Cydan Expands Team to Accelerate Development of Innovative Treatments for Patients Living with Rare Diseases

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cydan, an orphan drug accelerator dedicated to creating therapies that improve the lives of people living with rare…

Nimbus Therapeutics Grows Scientific Team, Adding Leaders in Biology and Preclinical Development
March 20, 2019 Off

Nimbus Therapeutics Grows Scientific Team, Adding Leaders in Biology and Preclinical Development

By BusinessWire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nimbus Therapeutics, a biotechnology company applying deep computational expertise throughout drug discovery and development, today announced the addition…

March 20, 2019 Off

Global $490.11 Mn Flow Cytometry Market Growth, Trends, and Forecasts 2019-2024 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Flow Cytometry Market – Growth, Trends, and Forecast (2019 – 2024)” report has been added to ResearchAndMarkets.com’s offering.…

Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
March 20, 2019 Off

Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics

By BusinessWire

Pfizer and Vivet to collaborate on development of potential breakthrough therapy for Wilson disease Pfizer acquires 15% ownership stake in…

March 20, 2019 Off

Global Public Health Partnering Deal Trends, Players and Financials Directory 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Public Health Partnering 2014-2019: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. Global…

March 20, 2019 Off

Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases

By BusinessWire

BOSTON & COPENHAGEN, Denmark–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Zealand Pharma A/S (NASDAQ:ZEAL) today announced a collaboration to discover and…

Posts pagination

Previous 1 … 3,343 3,344 3,345 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine